PHASE 2 TRANSCRANIAL PROBE

PHASE 2 TRANSCRANIAL PROBE is an FDA 510(k)-cleared medical device (K894163) manufactured by Biosound, Inc.. This device is classified under the Radiology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on September 11, 1989. Regulation: 8.